Research funder · United States
Michael J. Fox Foundation for Parkinson's Research
Non-profit organization in the USA
- Grants since 2016
- 1 275
- Awarded, last 5 years (where amounts are published)
- —
- Funded works, last 5 years
- 3 085
- Funded works, all time
- 6 716
Grants
2017 · research · Improved Biomarkers and Clinical Outcome Measures
Predicting the Risk of Parkinson’s Disease with a Mathematical Formula
Tiago A. Mestre · University of Ottawa
2017 · research · Computational Science
International Study of Parkinson's-related Changes in Brain Pathways Using Imaging Technique
Neda Jahanshad · Mark And Mary Stevens Neuroimaging And Informatics Institute, Keck School Of Medicine, University Of
2017 · research · Access to Data and Biospecimens
LRRK2 in predicting Parkinson disease risk and progression in LRRK2 mutation carriers
Andrew West · Duke University
2017 · research · Research Grant
Drawing on the Parkinson's Progression Markers Initiative (PPMI) Data to Link Changes in the PINK1/Parkin Genes with Parkinson's Disease
Owen Anthony Ross · Mayo Clinic in Florida
2017 · research · Research Grant
Study of a Molecule to Prevent Alpha-Synuclein Clumping and Treat Parkinson's Disease
Maria C. Derosa · Carleton University
2017 · research · Research Grant
Searching for the Cause of Parkinson’s Disease in People with GBA Mutations
Tatiana Foroud · Indiana University
2017 · research · Research Grant
Development of a Clinical Flow Cytometry Assay for Accurate and Selective Measurement of GBA1 Activity in Peripheral Blood Mononuclear Cells
David Vocadlo · Simon Fraser University
2017 · research · Therapeutic Pipeline Program
Small-Molecule Inhibitor of Alpha-Synuclein Propagation in the Treatment of Parkinson's Disease
Edward A. Fon · McGill University
2017 · research · LRRK2 Biology Consortium
Investigating the Role of LRRK2 in Immunity and Susceptibility to Infection
Robert O. Watson · Texas A&M Health Science Center
2017 · research · Target Advancement Program
Farnesoid X Receptor to Reduce Neuroinflammation
Jason R. Richardson · Northeast Ohio Medical University
2017 · research · Improved Biomarkers and Clinical Outcome Measures
Regulation of the SNCA Gene in Parkinson's Disease
Mathias Toft · Oslo University Hospital
2017 · research · Oligomeric & pS129 Assay LEAPS
Quantification of S129 Phosphorylated Alpha-synuclein Using the AlphaLISA® Immunoassay Platform
Deniz Kirik · Lund University
2017 · research · Oligomeric & pS129 Assay LEAPS
Exploring the Use of Alpha-synuclein Assays for Translational Biomarkers and Pharmaceutical Intervention Trials
Omar El-Agnaf · Neurological Disorders Research Center, Qatar Biomedical Research Institute (qbri), Hamad Bin Khalif
2017 · research · Research Grant
Inflammatory Parkinson's Clinical Biomarker Profiling
Scott Shandler · Longevity Biotech (United States)
2017 · research · LRRK2 Biology Consortium
Development of Nanobodies as Novel Tools to Characterize LRRK2 as a Potential Drug Target for Parkinson's Disease
Wim Versées · Vrije Universiteit Brussel/vlaams Instituut Biotechnologie
2017 · research · LRRK2 Biology Consortium
Identification of Network, Activity and Behavioral Signatures of LRRK2 Expression
Stephen L. Cowen · Assistant Professor
2017 · research · Research Grant
Studying Alpha-synuclein Oligomers Using Oligomer-binding Antibodies
Poul Henning Jensen · Aarhus University
2017 · research · Access to Data & Biospecimens
Klotho and Parkinson’s disease
Laurie H. Sanders · Duke University
2017 · research · Computational Science
Using "Big Data" Methods to Better Plan Clinical Trials and Predict Outcomes of Parkinson's Disease
Jacquelyn Cragg · University Of British Columbia And University Of Zurich
2017 · research · Target Advancement Program
Antibody Therapy to Block Alpha-Synuclein Spread and Toxicity
Valina L. Dawson · The Institute For Cell Engineering At Johns Hopkins University School Of Medicine
2017 · research · LRRK2 Biology Consortium
The Role of Variations in the LRRK2 Gene in Parkinson's Disease
Mark R. Cookson · National Institute on Aging
2017 · research · Computational Science
Analyzing Data from the Parkinson’s Progression Markers Initiative to Identify Subtypes of Parkinson’s Disease
Fei Wang · Weill Cornell Medicine
2017 · research · LRRK2 Biology Consortium
Consequences of LRRK2 Rab Phosphorylation in Neurons and Astrocytes
Matthew J. Lavoie · University of Florida
2017 · research · Research Grant
From Nose to Diagnostics: Development of an Accessible Screening Platform for Early Diagnosis of Parkinson's Disease
Perdita Barran · University of Manchester
2017 · research · Research Grant
Development of PET Tracers for Synucleinopathies
Francesca Capotosti · AC Immune (Switzerland)
2017 · research · Research Grant
External Validation of Proteos Alpha-synuclein Pre-formed Fibrils
Caryl E. Sortwell · Michigan State University
2017 · research · Research Grant
Microbiome Biomarkers for Early-stage Detection and Stratification of Parkinson's Disease
Paul Wilmes · Luxembourg Centre for Systems Biomedicine
2016 · research · Priority Target Award
Advancing PINK1 Knockout Models of Parkinson’s
Matthew S. Goldberg · University of Alabama at Birmingham
2016 · research · Improved Biomarkers and Clinical Outcome Measures
Developing a Molecular Imaging Tool That Binds to Alpha-Synuclein and Inhibits Its Formation
Leif Schröder · Leibniz-institut F
2016 · research · Target Advancement Program
Insights into LRRK2 Kinase Inhibitors
Sabine Hilfiker · Rutgers, The State University of New Jersey
2016 · research · Target Advancement Program
Targeting the Lysosomal Pathway to Ease Mitochondrial Dysfunction in IPSC-Derived Neurons from People with Parkinson's and GBA Mutations
Michael R. Duchen · University College London
2016 · research · Target Advancement Program
Role of LRRK2 in Levodopa-induced Dyskinesia
Michael Gordon Kaplitt · Weill Cornell Medicine
2016 · research · Target Advancement Program
Using LRRK2 Computer Simulations to Identify Therapeutic Targets for Parkinson's Disease
Bahareh (Spring) Behrouz · Vincere Biosciences Inc
2016 · research · Therapeutic Pipeline Program
Effect of HDAC Inhibition in Models of Parkinson's Disease
Berkley A. Lynch · Rodin Therapeutics (United States)
2016 · research · Research Grant
Chemical Knockdown of LRRK2 by Small Molecule PROTACS
Dario Alessi · University of Dundee
2016 · research · Access to Data and Biospecimens
Total and Proteinase K-resistant Alpha-synuclein in BioFIND Samples
Ronit Sharon · Hebrew University of Jerusalem
2016 · research · Target Advancement Program
Evaluation of the Parkin Pathway to Study Neural Mitophagy
Miratul Muqit · University of Dundee
2016 · research · Target Advancement Program
Characterization of TNIK as a LRRK2 Kinase
R. Jeremy Nichols · Stanford University
2016 · research · Research Grant
Saliva Alpha-synuclein Levels in LRRK2 Mutation Carriers
Jing Zhang · University of Washington
2016 · research · Access to Data and Biospecimens
MicroRNAs as biomarkers of the prodromal stage of Parkinson disease’
Rubén Fernández-Santiago · Idibaps, Hospital Clinic, University Of Barcelona